Australia's Firebrick Pharma jumps on plan to launch Nasodine products in US retail market

Firebrick Pharma

29/09/2026 05:06

** Shares of Australia's Firebrick Pharma FRE.AX surge as much as 15.4% to A$0.03, their highest since September 17
** Stock on track for its best session since August 10, if current trend holds
** Pharma firm announces plan to launch Nasodine products in US retail pharmacy market
** Nasodine range includes nasal and throat sprays
** Says up to six regional pharmacy groups, representing about 700 stores, express intent to place early orders
** Stock down over 45% YTD

 (Reporting by Rajasik Mukherjee in Bengaluru)
 ((Rajasik.Mukherjee@thomsonreuters.com))